COMPANIES COVERED
SequenomDownload FREE Report Sample
Download Free sampleNon-Invasive Prenatal Testing is a method of determining the risk that the fetus will be born with certain genetic abnormalities. This testing analyzes small fragments of DNA that are circulating in a pregnant woman's blood
Non-Invasive Prenatal Testing Market contains market size and forecasts of Non-Invasive Prenatal Testing in Global, including the following market information:
Global Non-Invasive Prenatal Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Non-Invasive Prenatal Testing market was valued at 5025.8 million in 2021 and is projected to reach US$ 9932.2 million by 2028, at a CAGR of 10.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
High & Average Risk Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-Invasive Prenatal Testing include Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina and Berry Genomics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Non-Invasive Prenatal Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Invasive Prenatal Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Non-Invasive Prenatal Testing Market Segment Percentages, by Type, 2021 (%)
High & Average Risk
Low Risk
Global Non-Invasive Prenatal Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Non-Invasive Prenatal Testing Market Segment Percentages, by Application, 2021 (%)
0-12 Weeks
13-24 Weeks
25-36 Weeks
Global Non-Invasive Prenatal Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Non-Invasive Prenatal Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Invasive Prenatal Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Non-Invasive Prenatal Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sequenom
Roche
Natera
LabCorp
BGI Genomics
Quest Diagnostics
Illumina
Berry Genomics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy